We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Estrella Immunopharma
ESLA
$31.1M
| $87.7K | ﹤0.01% |
+56,236
| New | +$106K |
|
2702
Stereotaxis
STXS
$143M
| $87.2K | ﹤0.01% |
37,898
-87,906
| -70% | -$234K |
|
|
AOMR
2703
Angel Oak Mortgage REIT
AOMR
$208M
| $87K | ﹤0.01% |
+10,100
| New | +$90.3K |
|
2704
CALL
Equifax
EFX
$21.3B
| $86.8K | ﹤0.01% |
+400
| New | +$87.6K |
|
2705
CALL
Burlington
BURL
$23.4B
| $86.7K | ﹤0.01% |
+300
| New | +$81.4K |
|
2706
PUT
Medtronic
MDT
$114B
| $86.5K | ﹤0.01% |
900
+200
| +29% | +$19.4K |
|
2707
Seer Inc
SEER
$119M
| $85.5K | ﹤0.01% |
+46,701
| New | +$95.2K |
|
2708
Paramount Gold Nevada
PZG
$132M
| $85.4K | ﹤0.01% |
67,742
-169,745
| -71% | -$196K |
|
|
RENT
2709
Rent the Runway
RENT
$122M
| $83.7K | ﹤0.01% |
+10,586
| New | +$57.1K |
|
|
EM
2710
DELISTED
Smart Share Global Ltd
EM
| $82.2K | ﹤0.01% |
+70,223
| New | +$93.6K |
|
|
USBC
2711
USBC Inc
USBC
$137M
| $81.5K | ﹤0.01% |
+129,325
| New | +$109K |
|
|
BNY
2712
PUT
Bank of New York Mellon
BNY
$108B
| $81.3K | ﹤0.01% |
+700
| New | +$77.5K |
|
|
TGB
2713
Trekor Metals
TGB
$3.21B
| $80.4K | ﹤0.01% |
+14,200
| New | +$66.8K |
|
2714
Wrap Technologies
WRAP
$102M
| $80.3K | ﹤0.01% |
33,755
-134,226
| -80% | -$324K |
|
2715
CALL
Regeneron Pharmaceuticals
REGN
$83.2B
| $77.2K | ﹤0.01% |
100
-1,300
| -93% | -$883K |
|
2716
Palladyne AI
PDYN
$305M
| $77.1K | ﹤0.01% |
+18,109
| New | +$122K |
|
2717
Roadzen
RDZN
$108M
| $76.6K | ﹤0.01% |
31,766
-180,015
| -85% | -$276K |
|
2718
CALL
iShares Expanded Tech-Software Sector ETF
IGV
$15.1B
| $74K | ﹤0.01% |
700
-8,700
| -93% | -$956K |
|
2719
PUT
Estee Lauder
EL
$31.5B
| $73.3K | ﹤0.01% |
700
-400
| -36% | -$38.8K |
|
2720
CALL
Palantir
PLTR
$421B
| $71.1K | ﹤0.01% |
+400
| New | +$72.4K |
|
2721
New Fortress Energy
NFE
$97.8M
| $70.5K | ﹤0.01% |
61,830
-515,949
| -89% | -$761K |
|
2722
Leslie's
LESL
$10.4M
| $69.9K | ﹤0.01% |
42,344
-3,796
| -8% | -$12.3K |
|
|
IMMP
2723
Immutep
IMMP
$56.6M
| $69.7K | ﹤0.01% |
+24,373
| New | +$51.3K |
|
2724
PUT
Zoom
ZM
$31.4B
| $69K | ﹤0.01% |
800
| – | – |
|
2725
CALL
Constellation Brands
STZ
$22.8B
| $69K | ﹤0.01% |
+500
| New | +$68.6K |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.